僅用于工業(yè)應(yīng)用或科學(xué)研究，不可用于人類或動物的臨床診斷或治療，非藥用. Orticumab （MLDL1278A） is an antibody targeting to oxidized or malondialdehyde-modified lipoprotein （LDL）. Orticumab specifically inhibits oxidized low-density lipoproteins （oxLDL）. Orticumab involves in modulation of autoimmune responses against oxLDL, improves atherosclerosis in animal model. Orticumab also can be used for research of psoriasis improvement